🇺🇸 FDA
Pipeline program

SZ011 CAR-NK

PCZCTP-220702-001

Phase 1 small_molecule active

Quick answer

SZ011 CAR-NK for Advanced Triple Negative Breast Cancer is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Advanced Triple Negative Breast Cancer
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials